Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 132, Issue 26
December 27 2018
Issue Cover

Table of Contents

BLOOD COMMENTARIES

MYELOID NEOPLASIA
Accelerating myelofibrosis through loss of Dnmt3a
Radek C. Skoda
View Articletitled, Accelerating myelofibrosis through loss of <em>Dnmt3a</em>
Lymphoid Neoplasia
Tropism of PCNSL: is it all about autoantigens?
Björn Chapuy
View Articletitled, Tropism of PCNSL: is it all about autoantigens?

PLENARY PAPER

MYELOID NEOPLASIA
Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation
Sebastien Jacquelin,Jasmin Straube,Leanne Cooper,Therese Vu,Axia Song,Megan Bywater,Eva Baxter,Matthew Heidecker,Brad Wackrow,Amy Porter,Victoria Ling,Joanne Green,Rebecca Austin,Stephen Kazakoff,Nicola Waddell,Luke B. Hesson,John E. Pimanda,Frank Stegelmann,Lars Bullinger,Konstanze Döhner,Raajit K. Rampal,Dirk Heckl,Geoffrey R. Hill,Steven W. Lane
View Articletitled, Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation
Supplemental data

PERSPECTIVE

Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!
Clinical Trials & Observations
Martin Dreyling,Wolfram Klapper,Simon Rule
View Articletitled, Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia
Wanling Sun,Zhijie Wu,Zenghua Lin,Maile Hollinger,Jichun Chen,Xingmin Feng,Neal S. Young
View Articletitled, Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia
Supplemental data

LYMPHOID NEOPLASIA

Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
Lorenz Thurner,Klaus-Dieter Preuss,Moritz Bewarder,Maria Kemele,Natalie Fadle,Evi Regitz,Sarah Altmeyer,Claudia Schormann,Viola Poeschel,Marita Ziepert,Silke Walter,Patrick Roth,Michael Weller,Monika Szczepanowski,Wolfram Klapper,Camelia Monoranu,Andreas Rosenwald,Peter Möller,Sylvia Hartmann,Martin-Leo Hansmann,Andreas Mackensen,Henning Schäfer,Elisabeth Schorb,Gerald Illerhaus,Rolf Buslei,Rainer Maria Bohle,Stephan Stilgenbauer,Yoo-Jin Kim,Michael Pfreundschuh
View Articletitled, Hyper-<em>N</em>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
Supplemental data

PLATELETS AND THROMBOPOIESIS

Direct Rap1/Talin1 interaction regulates platelet and neutrophil integrin activity in mice
Thomas Bromberger,Sarah Klapproth,Ina Rohwedder,Liang Zhu,Laura Mittmann,Christoph A. Reichel,Markus Sperandio,Jun Qin,Markus Moser
View Articletitled, Direct Rap1/Talin1 interaction regulates platelet and neutrophil integrin activity in mice
Supplemental data

TRANSPLANTATION

Nrf2 regulates CD4+ T cell–induced acute graft-versus-host disease in mice
Jennifer J. Tsai,Enrico Velardi,Yusuke Shono,Kimon V. Argyropoulos,Amanda M. Holland,Odette M. Smith,Nury L. Yim,Uttam K. Rao,Fabiana M. Kreines,Sophie R. Lieberman,Lauren F. Young,Amina Lazrak,Salma Youssef,Ya-Yuan Fu,Chen Liu,Cecilia Lezcano,George F. Murphy,Il-Kang Na,Robert R. Jenq,Alan M. Hanash,Jarrod A. Dudakov,Marcel R. M. van den Brink
View Articletitled, Nrf2 regulates CD4<sup>+</sup> T cell–induced acute graft-versus-host disease in mice
Supplemental data

LETTERS TO BLOOD

The genomic landscape of plasma cells in systemic light chain amyloidosis
Eileen M. Boyle,Cody Ashby,Christopher P. Wardell,Dorota Rowczenio,Sajitha Sachchithanantham,Yan Wang,Sarah K. Johnson,Michael A. Bauer,Niels Weinhold,Martin F. Kaiser,David C. Johnson,John R. Jones,Charlotte Pawlyn,Paula Proszek,Carolina Schinke,Thierry Facon,Charles Dumontet,Faith E. Davies,Gareth J. Morgan,Brian A. Walker,Ashutosh D. Wechalekar
View Articletitled, The genomic landscape of plasma cells in systemic light chain amyloidosis
Supplemental data
Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14)
Clinical Trials & Observations
Alice Cleynen,Mehmet Samur,Aurore Perrot,Laure Buisson,Sabrina Maheo,Mariateresa Fulciniti,Michel Attal,Nikhil Munshi,Hervé Avet-Loiseau,Jill Corre
View Articletitled, Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14)

BLOOD WORK

When eosinophils spill the beans…
Bouchra Badaoui,Orianne Wagner-Ballon
View Articletitled, When eosinophils spill the beans…

ERRATUM

Ciurea SO, Schafer JR, Bassett R, et al. Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation. Blood. 2017;130(16):1857-1868.
View Articletitled, Ciurea SO, Schafer JR, Bassett R, et al. Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation. <em>Blood</em>. 2017;130(16):1857-1868.
All Issues

Advertisement intended for health care professionals

Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma
Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19
The Contribution of the Monocyte‐Macrophage Lineage to Immunotherapy Outcomes

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals